Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8- Month Increase in Overall Survival in Patients with Advanced Soft Tissue Sarcoma, as Reported by Lilly and Memorial Sloan Kettering Researchers. By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Eli Lilly and Company announced that The Lancet published detailed
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Data detailed on Biological Factors have been presented. According to news reporting out of Chongqing, People's Republic of China, by NewsRx editors, research stated, "Antidepressants selectively inhibiting serotonin reuptake represent a highly effective drug class, and novel.
With hundreds of thousands of prescription drugs on the market, the pharmaceutical sector faces an increasingly complex and risky challenge. Rapid growth in the number of available medications may be contributing to increased uncertainties. Lisa Spellman, Director of Global Standards for the American Health Information Management Association and...
By a News Reporter-Staff News Editor at Heart Disease Weekly AstraZeneca announced clinical and safety data for osimertinib in patients with leptomeningeal disease, a complication of epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer, 1 where cancer cells spread to the cerebrospinal fluid. The updated BLOOM Pha
By a News Reporter-Staff News Editor at Heart Disease Weekly Takeda Pharmaceuticals Company Limited, will present eight abstracts at the American Diabetes Association's 76 Scientific Sessions, which takes place in New Orleans, LA, on June 10-14, 2016. "Type 2 diabetes is a progressive disease that can lead to serious cardiovascular comorbidities
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, announces that it has agreed to acquire a portfolio of six injectable products and their related customer contracts from Pfizer Inc.. The divestiture of these products was mandated by the European Commission as a condition to Pfizers acquisition of Hospira and the Europ
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAO, Jingtai; HU, Ying; ROMANO, Carmelo; WIEGAND, Stanley J., filed on December 1, 2015, was made available online on June 9, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appli
In Adam Haslett's beautiful new novel, Imagine Me Gone, mental illness rips through one New England family over the course of four decades. Under the care of his father's psychiatrist, Michael falls into a vicious cycle of prescription-drug dependence while his younger and more capable siblings, Celia and Alec, spend much of their adult lives strug
Alliance Pharma plc stock had its buy rating reaffirmed by investment analysts at Numis Securities Ltd in a report released on Friday. Shares of Alliance Pharma plc opened at 44.6875 on Friday. Alliance Pharma plc has a 1- year low of GBX 39.50 and a 1- year high of GBX 63.00.
Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes from European Medicines Agency. -Atara Biotherapeutics, Inc., a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases, today announced...
BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and contract research organizations to bring treatments and devices to the market since its inception. Today, BTC Network has grown to represent 63 full service, multi-specialty clinical research sites acros
-Australian microbiome biopharmaceutical company Immuron Limited, is pleased to announce that the Company has executed Research and Development Collaboration Agreement for the development of a Shigella vaccine with the Walter Reed Army Institute of Research. Established in 1893, and based in Silver Spring, Maryland, the Walter Reed Army Institute o
Khang& Khang LLP announces that a class action lawsuit has been filed against Chiasma, Inc.. The Company failed to disclose that the Phase 3 clinical trial for its oral octreotide, Mycapssa, which was conducted before the July 15, 2015 IPO, was insufficient to prove efficacy and secure FDA approval. On April 18, 2016 the Company announced that the
The Russian government has appointed the National immuno-biological company, the recently established Russian drugmaker which is part of the Russian state and defense corporation Rostec, as sole supplier of blood plasma drugs for the period of 2016-2017 years through the signing of a contract with the company. This has already been criticized by ot
Bahrain: The use of 5- Aminolevulinic as a diagnostic and therapeutic agent in medicine was the focus of a symposium organised by the Royal College of Surgeons in Ireland Medical University of Bahrain in collaboration with Japanese pharmaceutical company SBI Pharma.
OBS Pakistan, which has a taste for multinational companies, is acquiring Pakistan operations of German based Merck Serono, The News has learnt. OBS Pakistan earlier acquired MSD Pakistan in 2010 and now the locally owned pharmaceutical giant is after Merck Serono. Arshad Saeed said the overly regulated pharmaceutical market of Pakistan was no more
Pharma Bureau, the representative body of the research based multinational pharmaceutical companies operating in Pakistan, has suggested the government to follow the Indian example of revising its drugs law. The Indians are trying to help their pharmaceutical industry and Pakistani authorities should learn from this positive step of Indian governme
Pharma Bureau, the representative body of the research based multinational pharmaceutical companies operating in Pakistan, has suggested the government follow the Indian example of revising its drugs law. But that has now been withdrawn as the Indian authorities have realized, as they look to bringing in huge amounts of foreign investment, that the
The Sabin Vaccine Institute is partnering with King Saud University in Riyadh, Saudi Arabia, to advance vaccine research and development capacity in the Middle East and North Africa. In collaboration with the Prince Naif Bin Abdulaziz Health Research Center at King Saud University and Baylor College of Medicine, the goal of the project is to equip
Novartis has crossed all of the legal hurdles and launched its biosimilar of Neupogen, but its patent fight with Amgen was extended when the Swiss drugmaker asked the U.S. Supreme Court to get involved. In question are a number of issues that are key to Novartis ambitious biosimilars plans going forward; those issues will determine in whose pocket,
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming Deadline CHMA. -Pomerantz LLP announces that a class action lawsuit has been filed against Chiasma, Inc. and certain of its officers. The class action, filed in United States District Court, District of Mas
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline EGRX. -Pomerantz LLP announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. and certain of its officers. The class action, filed in United States Di
-T3D Therapeutics, Inc., a clinical stage drug development company targeting Alzheimers disease, is announcing that the U.S. Food and Drug Administration has granted approval for a 26- week, open-label extension to its 2- week Phase 2 a clinical trial of T3D-959 in a limited number of subjects who completed the main Phase 2 a study for the treatmen
The major vendors in the market are AbbVie, F. Hoffmann-La Roche, Gilead Sciences, Johnson& Johnson, Novartis, and Teva Pharmaceuticals. Companies such as BioLineRx, Emergent BioSolutions, Infinity Pharmaceuticals, and TG Therapeutics are expected to enter the market during the forecast period. Any company that manufactures and markets drugs that c
-Research and Markets has announced the addition of the "The World Market for Companion Diagnostic Tests" report to their offering. The World Market for Companion Diagnostics The World Market for Companion Diagnostics covers the world market for companion diagnostic and personalized medicine diagnostics. The phrase Companion Diagnostics Market...